ADANX
Price
$13.26
Change
+$0.02 (+0.15%)
Updated
Aug 21 closing price
Net Assets
2.87B
CVSCX
Price
$16.56
Change
+$0.01 (+0.06%)
Updated
Aug 21 closing price
Net Assets
18.6B
Interact to see
Advertisement

ADANX vs CVSCX

ADANX vs CVSCX Comparison Chart in %
View a ticker or compare two or three
VS
ADANX vs. CVSCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADANX is a Hold and CVSCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CVSCX has more cash in the bank: 18.6B vs. ADANX (2.87B). ADANX pays higher dividends than CVSCX: ADANX (1.80) vs CVSCX (0.78). ADANX was incepted earlier than CVSCX: ADANX (18 years) vs CVSCX (27 years). ADANX (2.05) and CVSCX (2.01) have similar cost to investors . ADANX is a more actively managed with annual turnover of: 410.00 vs. CVSCX (43.00). ADANX (2500) and CVSCX (2500) have matching initial minimum investment requirements. CVSCX (5.66) and ADANX (5.61) have marching annual gain over last year. CVSCX (16.46) and ADANX (16.34) have equivalent 5 years return.
ADANXCVSCXADANX / CVSCX
Total Expense Ratio2.052.01102%
Annual Report Gross Expense Ratio2.052.01102%
Fund Existence18 years27 years-
Gain YTD3.5133.522100%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.87B18.6B15%
Annual Yield % from dividends1.800.78230%
Returns for 1 year5.615.6699%
Returns for 3 years17.0315.22112%
Returns for 5 years16.3416.4699%
Returns for 10 years84.3530.77274%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSVAX15.940.09
+0.57%
Columbia Sm Cp Val and Inflection Inst
KCEIX13.980.06
+0.43%
Knights of Columbus Long/Short Eq I
MLRSX12.110.05
+0.41%
NYLI Winslow Large Cap Growth Class R6
VMIDX26.49N/A
N/A
VALIC Company I Mid Cap Index
MEYWX10.90N/A
N/A
Manning & Napier Equity Series W